focus -WSS

focus

author：hotspot 2025-09-06 03:28:21 - browse：16791

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

The benefits and risks of Eli Lilly’s treatment for Alzheimer’s disease were confirmed in detailed scientific disclosures Monday, paving the way for its full approval but leaving physicians with lingering questions about the medicine’s impact on patients as a new era in Alzheimer’s therapy unfolds.

The drug, called donanemab, showed a 35% slowing of Alzheimer’s disease progression relative to placebo in a clinical trial that enrolled 1,700 patients with early-stage disease. Numerically, that’s a modest, 3.3-point improvement on a 144-point survey, called the Integrated Alzheimer’s Disease Rating Scale, or iADRS, that combines measures of cognition and function, such as driving, managing finances, or carrying on conversations.

There was a similar benefit when donanemab’s efficacy was assessed using a more common measure of cognition called the Clinical Dementia Rating-Sum of Boxes, or CDR-SB. On that scale, the Lilly drug showed a 36% slowing of cognitive decline relative to placebo, or 0.68 points on an 18-point scale.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Paxlovid rebound happens. Why and to whom are still a mystery

WSS

St. Louis police protesters begin picking up checks in $4.9 million settlement

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Extensive review finds private equity owners jack up cost of care

Many breast cancer patients receive more radiation than needed

Are infertility treatments 'essential' during the Covid

How a Boston hospital is priming medical residents to use GPT

focus

focus

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

A new ‘biological computer' targets cancer while sparing healthy cells

Guidelines to prevent youth baseball injuries need more muscle

There’s a way to spot data fakery. All journals should be using it

Medicare details structure of new drug price negotiation program

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

New air purifier tech could be key to improving indoor air quality

Kansas bar where gunfire wounded 9 last month closes permanently

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

'Brian's Song' at 50 still offers lessons about cancer for today

explore

Many breast cancer patients receive more radiation than needed

After a decade, new Gardasil ad campaign gets it (mostly) right

US jobless claims fall again as labor market continues to flash strength

US jobless claims fall again as labor market continues to flash strength

Judge denies Trump's request for new trial in E. Jean Carroll case

Election results set back Medicaid expansion plans

knowledge

knowledge

focus

entertainment